<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Schroders Capital Global Innovation Trust Plc - Inov — News on 6ix</title>
    <link>https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov</link>
    <description>Latest news and press releases for Schroders Capital Global Innovation Trust Plc - Inov on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Thu, 09 Apr 2026 14:52:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/schroders-capital-global-innovation-trust-plc-inov" rel="self" type="application/rss+xml" />
    <item>
      <title>Director/PDMR Shareholding</title>
      <link>https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/directorpdmr-shareholding-846</link>
      <guid isPermaLink="true">https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/directorpdmr-shareholding-846</guid>
      <pubDate>Thu, 09 Apr 2026 14:52:00 GMT</pubDate>
      <description>Jane Tufnell, a Director at Schroders Capital Global Innovation Trust plc, has purchased 81,903 ordinary shares at a price of £0.1449 per share, totaling £11,867.74. This transaction occurred on April 9, 2026, on the London Stock Exchange. This initial notification indicates a direct investment by a key insider into the company&apos;s stock.
                Disclaimer*</description>
    </item>
    <item>
      <title>Annual Financial Report on NSM</title>
      <link>https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/annual-financial-report-on-nsm-9</link>
      <guid isPermaLink="true">https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/annual-financial-report-on-nsm-9</guid>
      <pubDate>Wed, 01 Apr 2026 15:44:00 GMT</pubDate>
      <description>Schroders Capital Global Innovation Trust plc has announced the release of its Annual Report and Financial Statements for the year ended 31 December 2025, along with the Notice of Annual General Meeting. These documents have been submitted to the National Storage Mechanism and are available on the company&apos;s website. The regulated information required under DTR 6.3.5 is included in full within these reports.
                Disclaimer*</description>
    </item>
    <item>
      <title>Final Results</title>
      <link>https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/final-results-605</link>
      <guid isPermaLink="true">https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/final-results-605</guid>
      <pubDate>Tue, 31 Mar 2026 06:00:00 GMT</pubDate>
      <description>Schroders Capital Global Innovation Trust PLC has released its annual report for the year ended 31 December 2025, detailing a strategic shift towards a managed wind-down and asset realization. The company successfully returned £37 million to shareholders in July 2025 and anticipates a further capital return of approximately £18 million in June 2026, subject to shareholder approval. The Net Asset Value (NAV) per share increased by 11.5% to 22.23p, while the share price saw a significant increase </description>
    </item>
    <item>
      <title>Block listing Interim Review</title>
      <link>https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/block-listing-interim-review-301</link>
      <guid isPermaLink="true">https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/block-listing-interim-review-301</guid>
      <pubDate>Thu, 26 Feb 2026 14:56:00 GMT</pubDate>
      <description>Schroders Capital Global Innovation Trust plc has filed a six-monthly block listing return for the period ending 24 February 2026. The company reported a balance of 52,999,999 unallotted securities from its previous return. During this period, the block scheme was not increased, and no securities were issued or allotted, resulting in the same balance of 52,999,999 securities remaining unissued and unallotted at the end of the reporting period.
                Disclaimer*</description>
    </item>
    <item>
      <title>Holding(s) in Company</title>
      <link>https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/holdings-in-company-1026</link>
      <guid isPermaLink="true">https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/holdings-in-company-1026</guid>
      <pubDate>Wed, 11 Feb 2026 16:13:00 GMT</pubDate>
      <description>Momentum Global Investment Management Ltd has increased its voting rights in Schroder Capital Global Innovation Trust PLC to 5.07%, holding 32,191,533 shares. This represents an increase from their previous holding of 4.95%. The acquisition of voting rights occurred on February 10, 2026, and the notification was made on February 11, 2026.
                Disclaimer*</description>
    </item>
    <item>
      <title>Sale of Bluewater Bio Limited</title>
      <link>https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/sale-of-bluewater-bio-limited</link>
      <guid isPermaLink="true">https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/sale-of-bluewater-bio-limited</guid>
      <pubDate>Tue, 20 Jan 2026 07:00:00 GMT</pubDate>
      <description>Schroders Capital Global Innovation Trust plc has announced the sale of its underlying portfolio company, Bluewater Bio Limited, through its holding in the Salica Environmental Technology Fund. This exit is expected to generate a distribution of £6.5 million to the Company, representing a significant realization event as part of the ongoing wind-down process approved by shareholders in February 2025. The sale&apos;s financial impact is anticipated to be in line with the Company&apos;s Q3 2025 Net Asset Va</description>
    </item>
    <item>
      <title>Quarterly NAV Announcement - 30 September 2025</title>
      <link>https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/quarterly-nav-announcement-30-september-2025</link>
      <guid isPermaLink="true">https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/quarterly-nav-announcement-30-september-2025</guid>
      <pubDate>Fri, 28 Nov 2025 07:00:00 GMT</pubDate>
      <description>Schroders Capital Global Innovation Trust plc reported a net asset value (NAV) per share of 21.42p as of 30 September 2025, unchanged from the previous quarter, with total NAV decreasing to £136.1 million from £173.2 million primarily due to a £37 million capital return to shareholders. The company is undergoing a managed wind-down, with performance benefiting from an upward revaluation of Revolut but offset by declines in Bizongo, Ada Health, and AgroStar. As of the reporting date, the company </description>
    </item>
    <item>
      <title>Sale of Securiti AI</title>
      <link>https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/sale-of-securiti-ai</link>
      <guid isPermaLink="true">https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/sale-of-securiti-ai</guid>
      <pubDate>Mon, 27 Oct 2025 07:00:00 GMT</pubDate>
      <description>Schroders Capital Global Innovation Trust plc announced that its portfolio company, Securiti AI, will be acquired by Veeam Software for US $1.725 billion. Schroders Capital has indirectly invested in Securiti since 2019, with a direct investment made in November 2023. The Manager estimates a positive valuation adjustment of 2.35% to the 30 June 2025 net asset value (NAV). Factoring in the tender offer announcement, this equates to an approximate NAV increase of 2.90%. This increase reflects the </description>
    </item>
    <item>
      <title>Half-year Report</title>
      <link>https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/half-year-report-639</link>
      <guid isPermaLink="true">https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/half-year-report-639</guid>
      <pubDate>Thu, 18 Sep 2025 06:00:00 GMT</pubDate>
      <description>Schroders Capital Global Innovation Trust reported a NAV per share increase of 7.4% to 21.42p in the six months ending June 30, 2025, from 19.94p at the end of 2024. The life sciences portfolio, particularly the revaluation of Araris Biotech, significantly contributed to this performance. The company completed a capital return of £37 million less costs, exceeding the initially projected £30 million, at a price of 21.119983 pence per ordinary share. Realizations of equities totaled £30.2 million </description>
    </item>
    <item>
      <title>Result of Tender Offer</title>
      <link>https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/result-of-tender-offer-45</link>
      <guid isPermaLink="true">https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/result-of-tender-offer-45</guid>
      <pubDate>Fri, 25 Jul 2025 06:00:00 GMT</pubDate>
      <description>Result of Tender Offer.</description>
    </item>
    <item>
      <title>Tender Offer Reminder</title>
      <link>https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/tender-offer-reminder</link>
      <guid isPermaLink="true">https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/tender-offer-reminder</guid>
      <pubDate>Fri, 11 Jul 2025 06:00:00 GMT</pubDate>
      <description>Tender Offer Reminder.</description>
    </item>
    <item>
      <title>Result of General Meeting</title>
      <link>https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/result-of-general-meeting-287</link>
      <guid isPermaLink="true">https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/result-of-general-meeting-287</guid>
      <pubDate>Thu, 10 Jul 2025 15:23:00 GMT</pubDate>
      <description>Result of General Meeting.</description>
    </item>
    <item>
      <title>Circ re. Tender Offer</title>
      <link>https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/circ-re-tender-offer</link>
      <guid isPermaLink="true">https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/circ-re-tender-offer</guid>
      <pubDate>Thu, 19 Jun 2025 06:00:00 GMT</pubDate>
      <description>Circ re. Tender Offer.</description>
    </item>
    <item>
      <title>Quarterly NAV Announcement - 31 March 2025</title>
      <link>https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/quarterly-nav-announcement-31-march-2025</link>
      <guid isPermaLink="true">https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/quarterly-nav-announcement-31-march-2025</guid>
      <pubDate>Thu, 22 May 2025 06:00:00 GMT</pubDate>
      <description>Quarterly NAV Announcement - 31 March 2025.</description>
    </item>
    <item>
      <title>Result of AGM</title>
      <link>https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/result-of-agm-932</link>
      <guid isPermaLink="true">https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/result-of-agm-932</guid>
      <pubDate>Wed, 21 May 2025 14:51:00 GMT</pubDate>
      <description>Result of AGM.</description>
    </item>
    <item>
      <title>Virtual Presentation</title>
      <link>https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/virtual-presentation-1</link>
      <guid isPermaLink="true">https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/virtual-presentation-1</guid>
      <pubDate>Tue, 25 Mar 2025 15:09:00 GMT</pubDate>
      <description>Virtual Presentation.</description>
    </item>
    <item>
      <title>Sale of Araris Biotech</title>
      <link>https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/sale-of-araris-biotech</link>
      <guid isPermaLink="true">https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/sale-of-araris-biotech</guid>
      <pubDate>Mon, 17 Mar 2025 09:40:00 GMT</pubDate>
      <description>Sale of Araris Biotech.</description>
    </item>
    <item>
      <title>Total Voting Rights</title>
      <link>https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/total-voting-rights-728</link>
      <guid isPermaLink="true">https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/total-voting-rights-728</guid>
      <pubDate>Fri, 28 Feb 2025 17:10:00 GMT</pubDate>
      <description>Total Voting Rights.</description>
    </item>
    <item>
      <title>Transaction in Own Shares</title>
      <link>https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/transaction-in-own-shares-729</link>
      <guid isPermaLink="true">https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/transaction-in-own-shares-729</guid>
      <pubDate>Thu, 27 Feb 2025 15:40:00 GMT</pubDate>
      <description>Transaction in Own Shares.</description>
    </item>
    <item>
      <title>Publication of a Circular and Notice of GM</title>
      <link>https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/publication-of-a-circular-and-notice-of-gm-2</link>
      <guid isPermaLink="true">https://6ix.com/company/schroders-capital-global-innovation-trust-plc-inov/news/publication-of-a-circular-and-notice-of-gm-2</guid>
      <pubDate>Fri, 31 Jan 2025 07:00:00 GMT</pubDate>
      <description>Publication of a Circular and Notice of GM.</description>
    </item>
  </channel>
</rss>